Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

导出原文传递

翻译打印收藏纠错

作者： Lavin, V. ^[1] ; Whitehurst, P. ^[2] ; Harris, C. ; Goldstraw, R. ; Bayman, N. ; Chan, C. ; Coote, J. ; Harris, M. ; Pemberton, L. ; Sheikh, H. ; Woolf, D. ; Faivre-Finn, C.

作者单位： Christie Hosp NHS Fdn Trust, Med Phys, BX, Manchester, Lancs, England ^[1] Christie Hosp NHS Fdn Trust, Clin Oncol, BX, Manchester, Lancs, England ^[2]

发布时间 2020-08-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Lung cancer

2017年103卷Suppl.1期

S53-S54页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

Lung cancer

相似文献

Lung cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

Lung cancer

相似文献

Lung cancer

相关期刊

检索历史清除